5-(4-fluoro-3-methylphenyl)-5-oxovaleric acid, 97.0%, 2g

methyl 4-hydroxybicyclo[2.2.2]octane-1-carboxylate, 97.0%, 500mg

4,4'-Di-tert-butyl-2,2'-bipyridine, 95.0%, 10g

1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-5-propyl-1H-pyrazole-4-carboxylic acid, 95.0%, 500mg

3-(2,5-Dimethyl-1-propyl-1h-pyrrol-3-yl)-3-oxopropanenitrile, 97%, 100mg

(4-bromo-1-methyl-1H-pyrazol-5-yl)methanol, 95.0%, 250mg

2-Ethylsulfanyl-1H-benzoimidazole, 97.0%, 250mg

3-Iodotoluene>98.0%(GC)500g

Columna capilar GC ROTI®Cap-1, 50 m, 0,32 mm, 0,50 µm, 1 Pieza(s)

5-tert-Butyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-glutamate>98.0%(HPLC)(T)5g

(R)-4-((tert-Butoxycarbonyl)amino)-4-phenylbutanoic acid, 98%, 100mg

4-Nitrophenyl alpha-D-Glucopyranoside [Substrate for alpha-D-Glucosidase]>98.0%(HPLC)5g

3-Methoxy-2-methylphenol, 1g